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Application of retinoic acid improves form and function
of tissue engineered corneal construct
Fadhilah Z Abidin, Ricardo M Gouveia, and Che J Connon*
Institute of Genetic Medicine; Newcastle University; Center for Life; Newcastle, UK
ABSTRACT. Retinoic acid has recently been shown to control the phenotype and extracellular
matrix composition of corneal stromal cells cultured in vitro as monolayers. This study set out to
investigate the effects of retinoic acid on human corneal keratocytes within a 3D environment.
Human corneal keratocytes were encapsulated in collagen gels, which were subsequently compressed
under load, and cultured in serum-free media supplemented with 10 mM retinoic acid or DMSO
vehicle for 30 days. Cell proliferation was quantified on selected days, while the expression of
several important keratocytes markers was evaluated at day 30 using RT-PCR and immunoblotting.
The weight and size of the collagen constructs were measured before and after hydration and
contraction analyses. Retinoic acid enhanced keratocyte proliferation until day 30, whereas cells in
control culture conditions showed reduced numbers after day 21. Both gene and protein expressions
of keratocyte-characteristic proteoglycans (keratocan, lumican and decorin), corneal crystallins and
collagen type I and V were significantly increased following retinoic acid supplementation. Retinoic
acid also significantly reduced the expression of matrix metalloproteases 1, 3 and 9 while not
increasing a-smooth muscle actin and fibronectin expression. Furthermore, these effects were also
correlated with the ability of retinoic acid to significantly inhibit the contractility of keratocytes while
allowing the build-up of corneal stromal extracellular matrix within the 3D constructs. Thus, retinoic
acid supplementation represents a promising strategy to improve the phenotype of
3D-cultured keratocytes, and their usefulness as a model of corneal stroma for corneal biology and
regenerative medicine applications.
KEYWORDS. 3Dmodel, collagen gel, Cornea, in vitro, keratocytes, retinoic acid, tissue engineering
INTRODUCTION
The cornea is a transparent, avascular struc-
ture that provides optical transparency for light
transmission and light refraction for normal
vision as well as protection against external
environment.1,2 The World Health Organization
has estimated over 10 million people from
around the world suffer from corneal blindness
secondary to trauma, infection or hereditary
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diseases.3 Although transplantation is the pre-
vailing option to correct severe corneal
impairment, the sustainability of this treatment
of choice remains a great challenge. This is
mainly due to limited supply of corneas from
healthy corneal donors, and is made worse by
the growth in refractive surgeries, which
degrade the cornea for subsequent use in trans-
plantation.4 These issues have fueled interest in
the development of tissue-engineered corneas
as a long-term strategy to address the aforemen-
tioned problems.5,6 In this context, natural bio-
logical materials such as collagen, has been
used to provide scaffolding support for corneal
tissue engineering with promising results.7-9
Collagens are one of the most abundant struc-
tural proteins within mammalian connective tis-
sue and represent almost one-third of total body
proteins.10 Collagen provides structural support
and mechanical stability while maintaining flexi-
bility in various tissues, such as skin,11 tendon,12
bone.13 and cornea.14 Collagen type-I is one of
the main structural elements of the extracellular
matrix of the corneal stroma. As such, its use as
a corneal tissue engineering scaffold has been
extensively studied.15-18 The use of collagen in
tissue engineering has been attributed to its bio-
compatibility, biodegradability and low-immu-
nogenicity.19 However, conventional collagen
gels are highly hydrated and therefore, difficult
to be manipulated.20 An additional step of
‘plastic compression’ following collagen gel for-
mation allows the controlled engineering of
collagen gels by rapid dehydration, and subse-
quently causing permanent deformation and a
marked increase in collagen fibril density.21,22
Compressed collagen gels are mechanically
robust structures comprised of compacted colla-
gen fibrils with a smooth surface topography.23
It has been suggested that compressed collagen
gels are a suitable mimic for the structure of bio-
logical materials,21 and several studies have used
corneal keratocytes in the collagen scaffold to
produce a 3D tissue culture to mimic the presence
of keratocytes in normal corneal stroma.24-28
Keratocytes are mesenchymal-derived, flat-
tened cells which sparsely populate the corneal
stroma.29,30 Their primary function is to syn-
thesize and maintain the extracellular matrix
(ECM) component of the stroma that comprises
the structural backbone of the cornea.31 Kerato-
cytes are quiescent in nature and exhibit slow
turn over.32 The ex vivo expansion of kerato-
cytes has been performed in order to investigate
its biology in vitro, but maintaining them in
their quiescent phenotype remains a consider-
able challenge. The use of serum-free media
was shown to maintain the quiescence pheno-
type, but not support proliferation, of corneal
stromal cells,33-35 thus making cultivation of
large quantities of cells by subculturing a diffi-
cult task. On the other hand, the addition of
serum to culture medium helps to accelerate
cell proliferation, but at the same time results
in the differentiation of keratocytes to fibro-
blasts with altered physiological and biochemi-
cal properties, namely its phenotype, keratan
sulfate production and the expressions of
certain genes such as a-smooth muscle actin,
aldehyde dehydrogenase (ALDH) and fibronec-
tin.29,34,36 Previous studies have tested several
media formulations that allow corneal stromal
cells to proliferate and survive for extended
period in culture while maintaining the expres-
sion of keratocyte-specific markers. In particu-
lar, fibroblast growth factor 1 (FGF-1),37 FGF-
2,38 FGF-2 C heparin,37 and transforming
growth factor b3 (TGF-b3)39 have been used to
reverse the serum-induced (myo)fibroblast
transformation. Therefore, the challenge now is
to find a new supplement for serum-free media
that allows cell growth and proliferation with-
out encouraging fibroblastic differentiation.
One of the possible supplements for serum-
free growth of keratocytes is retinoic acid (RA),
a molecule that plays a crucial role in vertebrate
development, cellular differentiation and homeo-
stasis,40-42 and is essential to ocular health.43-45
The human body produces RA, an active
form of vitamin A, through two sequential oxi-
dation steps: from retinol (absorbed by intesti-
nal mucosa cells following dietary ingestion) to
retinaldehyde, and then to RA.46 Its use has
been implicated in cutaneous wound healing,47-
49 and considerable interest has been steered
towards its application in ophthalmology. As
such, much of the current lines of research
focuses on its potential use in improving
corneal wound healing through faster epitheli-
alization,50-52 however, little is known about
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the effect RA has on corneal keratocytes in
their native 3D environment.
In this study, we sought to investigate the
effects of RA supplementation in serum-free
medium on corneal keratocytes in a 3D envi-
ronment for tissue engineering purposes. We
considered its effect on cell proliferation, colla-
gen production, hydration of tissue constructs
and the expression of keratocytes markers at
both transcriptional and protein levels in an
extended period of culture.
RESULTS
Effects of RA on keratocytes proliferation
The proliferation assays showed a steady
increase in the number of cells from day 3 to
day 30 in the RA-supplemented group and from
day 3 to day 21 in the control group (Fig. 1).
The cell numbers of keratocytes in collagen gels
cultured using medium with or without supple-
mentation of RA showed comparable values up
to 21 d in culture. However, keratocytes cultured
in medium supplemented with RA continued to
proliferate until day 30, whereas keratocytes cul-
tured in control medium showed a significant
decline in cell number. Hence, day 30 was taken
as the day for further assessment on the expres-
sion of keratocytes markers.
Effects of RA on engineered tissue
contraction assay
We used digital images of the engineered
stromal constructs to calculate the percentage
change in surface area relative to their initial
surface area following 30 d of culture
(Fig. 2A). The engineered stromal constructs
cultured in RA-supplemented medium suc-
cessfully maintained more than 95% of their
surface area at the end of the experiment
(Fig. 2B). On the other hand, the surface
area of the constructs cultured in serum-free
medium with DMSO (control) were reduced
by more than 20% of their original surface
area, and the constructs cultured with serum
(FBS) contracted more than 60% of their ini-
tial surface area. The differences in gel size
within the control and FBS groups were
significant for the duration of the experiment
(p < 0 .01 and < 0 .001, respectively).
Effects of RA on engineered tissue
hydration
Interestingly, there was a significant
increase in the wet weight of collagen gels con-
taining keratocytes supplemented with RA as
compared to the control after 30 d (Fig. 3, left
panel). Not only that, the results also showed
that collagen gels in the control groups reduced
their initial weight following the 30-day cul-
ture period. The dry weight of freeze-dried gels
from the RA-supplemented group was also
found to be significantly higher by 18% than
the controls (Fig. 3, central panel). At the
same time, the hydration percentage within
RA-supplemented collagen gels showed to be
higher compared to the collagen gels from the
control group (84 § 1 and 80 § 2%, respec-
tively; Fig. 3, right panel).
FIGURE 1. Effects of RA supplementation on
the proliferation of keratocytes embedded in
compressed collagen gels. Quantification was
performed using AlamarBlue assay, and cell
numbers were normalized as a percentage of
cells initially seeded. Data (mean § SD) were
obtained from 3 independent experiments (n D
3) and compared using t-test (*corresponds to
P < 0.05).
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Effects of RA on the expression
of keratocytes markers
Several important keratocytes markers were
analyzed at the gene transcript level and compared
with the control. Results showed that RA treat-
ment significantly increased transcription of genes
coding for key corneal proteoglycans (keratocan,
lumican and decorin) by 1436 § 12, 6410 § 37,
and 1510 § 5 % of the control, respectively
(Fig. 4). In addition, transcription levels of genes
coding for corneal crystallins (ALDH1 and
ALDH3), CHST6 and Collagen type V were also
studied and shown to increase by 1181§ 7, 3826
§ 38, 596 § 1 and 941 § 8 % of the control,
respectively. On the other hand, genes coding for
two keratocytes matrix metalloproteases, MMP1
and MMP9 were significantly down regulated to
6.6 § 0.04 and 5.2 § 0.04 %, respectively, when
compared to the control (Fig. 4). No difference
was observed for transcripts of ACTA2, the gene
coding for aSMA.
Furthermore, these data were supported by pro-
tein expression levels analyzed by immunoblot-
ting and quantified by densitometry. RA-
supplemented keratocytes showed significant per-
centage-increased expression for keratocan
(197.4 § 0.5), lumican (251.7 § 0.5), decorin
(321.2§ 0.5), Collagen type I (198.5§ 0.3), Col-
lagen type V (210.4 § 0.8), ALDH1 (575.9 §
2.9), ALDH3 (301.2§ 0.6) and CHST6 (689.0§
3.5) relative to the control (Fig. 5). Again similar
to gene transcript levels, the expression of
MMP-1 and MMP-3 in RA supplemented group
was significantly reduced to 7.4 § 0.08 and
10.1 § 0.07 % of the control levels, respectively
(Fig. 5). In addition, aSMA and fibronectin levels
were not affected by RA supplementation, and
remained residual compared with the heightened
levels normally seen in FBS-activated fibroblasts.
The localizations of these proteins, shown by
immunofluorescence analysis, were not sub-
stantially modified by RA supplementation
despite their stronger detections. However,
localization of Collagen type V was shown to
be similar throughout the depth of collagen
gels in both groups despite its stronger detec-
tion in the RA-supplemented group at both
transcriptional and protein levels (Fig. 6).
DISCUSSION
Our previous work has shown that using an
optimal concentration of RA encouraged the kera-
tocytes to grow and proliferate further without the
need for serum in the medium.53 In this study, we
extended the experiment into a 3D construct to
investigate the use of RA supplementation in the
generation of potential biologically relevant tis-
sue-engineered corneal stroma. The use of RA for
in vitro keratocytes studies holds great promise,
since we have shown that its supplementation suc-
cessfully induced proliferative potential of kerato-
cytes when used in serum-free medium over an
FIGURE 2. Contraction assay. (A) Contraction
assay of 3D collagen constructs embedded with
corneal keratocytes and cultured in serum-free
medium (with RA supplementation or DMSO
control) or standard medium (with serum; FBS).
The outer dotted line represents the size of the
gel at the beginning of the experiment. Scale
bar D 10 mm. (B) The gel size (in percentage)
was determined by calculating the difference in
constructs’ surface area between the initial day
of experiment (white bar) and day 30 (colored
bar). Data (mean § SD) were obtained from 3
independent experiments (n D 3) and compared
using t-test (** and *** correspond to P < 0.01
and <0.001, respectively).
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extended period in culture. This is important to tis-
sue engineering as engineered constructs, such as
the cornea, typically require many days in culture.
In the present study, we demonstrated that sup-
plementation of RA in serum-free medium to cul-
ture corneal fibroblasts in a 3D collagen construct
helped prevent cells from becoming fibroblastic
and remained more keratocyte-like as evidenced
by an increasing production of keratocyte-
markers and very low expressions of fibroblastic-
markers. Chemical cues are known as important
elements in the control and maintenance of the
keratocyte phenotype.35 A considerable challenge
in stromal cell culture is to encourage the kerato-
cytes to proliferate while at the same time main-
taining the keratocyte phenotype in order to
continue producing the ECM proteins essential
for optical transparency. Previous attempts have
been made towards obtaining a proliferating cul-
ture of ‘pure’ keratocytes, including supplementa-
tion with ascorbic acid,54 insulin,55 growth
factors,56 cytokines,57 and using low glucose
media.58 Within the 3D environment, we found
that RA significantly modulated the expression of
many keratocyte-characteristic ECM components
(keratocan, lumican, decorin), the corneal crystal-
lins (ALDH1, ALDH3) and carbohydrate
sulfotransferase 6 (CHST6), as well as increased
expression of both Collagen type I and V.
Keratocytes secrete Collagen type I and V,
which are the predominant fibrillar collagens in
the corneal stroma. In addition, the uniformity
of these fibrillar collagens (diameter and interfi-
brillar spacing) is important for the mainte-
nance of corneal function. Keratocan, lumican
and decorin belong to the family of small leu-
cine-rich proteoglycans (SLRPs) which serve
as regulators of tissue hydration and collagen
fibrillogenesis.59,60 These SLRPs bind to fibril-
lar collagens and affect the collagen matrix
assembly needed for corneal transparency.61
Furthermore, significant increases in ALDH1
and ALDH3 expression within the RA-supple-
mented group were also important findings.
Prominent ALDH isoenzymes in cornea, such
as ALDH1 and ALDH3, exert protective
effects from the harmful effects of UV-induced
lipid peroxidation,62-64 and maintain corneal
transparency.65 ALDH is produced in greater
amounts by quiescent keratocytes compared to
their activated phenotype, as shown both in
vitro (following exposure to serum)66,67 and in
vivo.68 As such, a decrease in corneal crystal-
lins is posited to increase light scattering by the
FIGURE 3. Effects of RA supplementation on the hydration of cell-encapsulating compressed col-
lagen gels. The weight of all gels was measured before and after the 30 d culture period to find the
differences in the wet weight. The dry weight was quantified following freeze-drying of the gels.
The percentage of hydration denotes the loss of bound water from the collagen gels with or without
supplementation of RA. Data (mean § SD) were obtained from 3 independent experiments (n D 3)
and compared using t-test (*** correspond to P <0.001).
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corneal fibroblasts, and decrease corneal trans-
parency.69 Interestingly, RA significantly mod-
ulated the expression of CHST6, an enzyme
that catalyzes the transfer of sulfate group to
keratan sulfate proteoglycans (KSPGs) to help
maintain corneal transparency. CHST6 is
mainly expressed by the keratocytes both in
vivo and in vitro.70 Defects in this gene are
associated with macular corneal dystrophy
(MCD), a rare autosomal recessive inherited
disorder characterized by abnormal deposits of
unsulfated KSPGs that causes progressive stro-
mal haziness leading to visual impairment.71,72
An increase synthesis of CHST6 following RA
supplementation suggests that RA is safe for
corneal keratocytes. At the same time, this
result implies the considerable potential for RA
to be used as a possible therapy for MCD, as
the aim in curing this rare genetic disorder
must involve and target corneal keratocytes.70
The expression of MMP1 (i.e. interstitial col-
lagenase) and MMP3 (i.e. stromelysin-1) was
greatly reduced following RA supplementation,
in line with previous findings73 in diabetic
human skin, which showed enhanced collagen
synthesis and reduction in MMP expression in
the presence of RA. Under normal circumstan-
ces, MMP-1 and MMP-3 are not synthesized by
quiescent keratocytes. However, the synthesis is
upregulated when the keratocyte’s phenotype
changes into that of repair fibroblasts.74,75 We
also evaluated the expression of a-SMA and
fibronectin and found that they appear to be
unaffected by the presence of RA in the cultures
i.e. low, as one would expect from serum-free
conditions.
The increase in ECM production following
RA-supplementation may also contribute to the
measured increase in both wet and dry weight of
the 3D collagen-keratocyte constructs. The wet
weight of gels significantly increased after the
30-days period in culture in RA conditions com-
pared to their initial wet weight, but decreased in
control gels, indicating that RA induced the resi-
dent keratocytes to 1) produce larger amounts of
newly-synthesized material, 2) enhanced the
gels’ ability to accumulate water, and/or 3) inhib-
ited degradation of the initial collagen gel scaf-
fold compared to control conditions. These
conclusions are supported by the significant
increase in dry weight of RA-treated gels
(Fig. 3, central panel), as well as by the RA-
induced enhancement of keratocyte-characteris-
tic ECM components and the abrogation of
MMP expression observed at the gene and
FIGURE 4. Expression of keratocyte markers at
the transcriptional level. Total mRNA from cells
embedded in compressed collagen gels cul-
tured for 30 d in control (gray) and CRA
(orange) was extracted and analyzed by RT-
PCR. Gene expression was normalized relative
to that of control group. Data (mean § SD) were
obtained from 3 independent experiments
(n D 3) and compared using t-test (*, ** and ***
correspond to P < 0.05, <0.01 and <0.001,
respectively).
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FIGURE 5. Expression of keratocyte markers at the protein level. (A) Lysates from corneal stroma
(CS), corneal fibroblasts cultured in FBS (FBS), or 3D stromal constructs supplemented with RA
(RA) or DMSO (Ctl) were extracted and analyzed by reducing SDS-PAGE followed by immunoblot-
ting. (B-E) Quantification of protein expression from control (gray) and RA (orange) was performed
by immunoblot densitometry for all markers. Protein expression was normalized relatively to that of
control group. Data (mean § SD) were obtained from 3 independent experiments (n D 3) and com-
pared using t-test (* correspond to P < 0.05 respectively).
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protein levels (Fig. 4 and 5 respectively). More-
over, the higher content of keratocyte-character-
istic proteoglycans (keratocan, lumican and
decorin) in the RA-treated group might account
for the higher capacity of these gels to retain
water (Fig. 3, right panel). As mentioned previ-
ously, the SLRPs serve as regulators for tissue
hydration. Since thereweremore SLRPs in colla-
gen constructs supplemented with RA, it was not
surprising that the water content within these
gels was higher compared to the control. There-
fore, both wet and dry weight values were impor-
tant to understand the dynamic changes in the
properties in this gel-keratocyte system, and
were necessary to determine the constructs’
hydration, an important property of the corneal
stroma and its transparency.
Importantly, the contraction assay confirmed
that the addition of RA significantly reduced con-
traction of engineered constructs compared to the
control gels. This is another positive finding
showing that RA was not only mitogenic, but
also maintained keratocytes in a non-contractile
phenotype. However, the potentially limiting
effects of increased collagen (as shown in the
presence of RA) on gel contraction cannot be dis-
regarded. The use of fetal bovine serum in the
culture medium to promote cell proliferation
results in contraction of the engineered matrix76
that often mimic scarred native tissue due to acti-
vation of stromal fibroblasts into myofibro-
blasts.77 While removal of serum can abrogate
this phenomenon, we have demonstrated that fur-
ther significant loss of contraction can be
achieved by the simple addition of RA.
MATERIALS AND METHODS
Human corneal keratocyte isolation
Corneal tissues were obtained from Royal
Berkshire Hospital, Reading, UK and
Royal Victoria Infirmary, Newcastle, UK.
Corneal stroma was excised from cadaverous
human limbal tissue following removal of the
central 7 mm for keratectomy (donors’ age
between 39 and 76; average § SD D 61 §
12 years, with no prior history of corneal dis-
eases or ocular trauma). The male-female
donor ratio was 2:3. Briefly, the epithelia-
depleted corneal tissues were minced using a
scalpel, transferred to DMEM:F12 medium
FIGURE 6. Immunofluorescence staining of
ECM proteins characteristic of the corneal
stroma, expressed by encapsulated keratocytes
within compressed collagen gels with or without
RA supplementation. All photographs were
taken at x200 magnification. Scale barD 50 mm.
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(Invitrogen, 31331–028) supplemented with
5% fetal bovine serum (FBS; Gibco Invitro-
gen, 10082–147), 2 g/L (450 units/ml) colla-
genase type-1 (Invitrogen, 17018–029) and
incubated at 37C under continuous rotation
for 5 hours, followed by incubation with
0.25% trypsin-EDTA (Gibco Invitrogen,
25200–072) for 10 minutes. The isolated kera-
tocytes were plated onto tissue culture flasks
(Greiner Bio-One, 658175) and maintained
using culture medium containing DMEM:F12
medium (Invitrogen), 5% FBS (Gibco Invitro-
gen), 1 £ 10¡3 M ascorbic acid (Sigma-Aldrich,
A8960), 1 £ ITS liquid media supplement
(Sigma-Aldrich, I3146) and 1% penicillin/
streptomycin (Invitrogen, 15140–122). The
culture medium was changed every 2–3 days
and cultures were maintained until reaching
70–80% confluence. Cells were then trans-
ferred to culture medium without FBS (serum-
free medium, SFM) to induce quiescence,
and passaged after 3 days. Corneal stromal
fibroblasts maintained in serum-containing
media have been previously shown56-58 to
revert to a more keratocyte-characteristic phe-
notype, expressing higher keratocyte-specific
markers58 while showing reduced cell migra-
tion and contractility after a 3-day period of
serum starvation.56-58,78 Each subsequent
experiment was performed 3 independent
times using keratocytes from passages 3 to 5
from specific donors.
Formation of compressed collagen gels
with embedded keratocytes
Collagen gels were prepared as previously
described.79 2 ml sterile rat-tail collagen type
I (2.2 mg/ml in 0.6% acetic acid, First Link
Ltd.,60–30–810) and 0.5 ml modified Eagle’s
minimum essential medium (MEM; Fisher
Scientific, 21430–020) were mixed in a cen-
trifuge tube placed on ice. Sodium hydroxide
1 M (Fisher Scientific, J/7620/15) was added
drop-wise to neutralize the pH of the mixture,
along with intermittent, gentle mixing of the
solution until it changed its color from yellow
to light pink. The mixture was then cast into
12-well plate molds (Greiner Bio-One,
665180), along with 2.5 £ 105 serum-
deprived keratocytes in each well prior to
polymerization (gelling), which subsequently
took place for 30 minutes at 37C in a humidi-
fied 5% CO2 incubator. Next, the polymerised
collagen gels containing keratocytes were
removed from the molds and placed in
between layers of nylon mesh, and the com-
pression was performed at room temperature
using a 134 g load for 5 minutes. The result-
ing compressed collagen gels embedded with
keratocytes were then transferred into 6-well
plates (Greiner Bio-One, 657160) and cul-
tured using SFM supplemented with either
1 £ 10¡7 M RA (CRA, Sigma-Aldrich,
R2625) or equivalent volume of DMSO vehi-
cle (control; Fisher Scientific, 10080110) for
30 days. The culture medium was changed
every 2–3 days.
Proliferation assay
The AlamarBlue assay was used to assess
keratocyte proliferation and viability within
the collagen gels with or without supplemen-
tation of RA in SFM for 30 days. The
gels were incubated with resazurin reagent
(Sigma-Aldrich, R7017; prepared in 1:10 dilu-
tion using fresh culture medium) for 2 h at
37C, after which 100 ml of culture superna-
tants were sampled in triplicate for fluores-
cence emission analysis at 590 nm using
Fluoroskan Ascent fluorescent spectropho-
tometer (Thermo Labsystems, Franklin, MA),
and cells replenished with fresh media. The
assay was done on days 3, 7, 21 and 30 of cul-
ture. Cell number was calculated by interpola-
tion using a standard curve for fluorescence
values of 1, 5, 10, 20, 50, and 100 £ 104 cells,
and the values correspond to average § SD of
3 independent experiments.
Hydration study
The weight of all cell-encapsulated collagen
gels from RA-supplemented and control groups
was measured before starting the experiment to
find the initial weight (Wi), and similarly after
the 30-day culture period for the final weight
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(Wf). The ratio of weight increment (wet
weight) was then calculated using the following
equation (Eq 1).
Wet weight ratioð ÞD final weight Wfð Þ
=initial weight Wið Þ (1)
Next, we used a freeze-drying method to
sublimate frozen water from the solid to gas
phase under controlled pressure in order to
determine the percentage of water bound to
these gels. The weight of all freeze-dried gels
were again measured to find the dry weight
(Wd), which was later used to find the hydration
percentage of all gels using the following equa-
tion (Eq 2).
Hydration %ð ÞD Wf ¡Wd/Wfð Þ£ 100 (2)
This experiment was performed 3 indepen-
dent times, using 3 replicate gels.
Gel contraction assay
Digital photography was used to image the
constructs at the beginning of the experiment
and on day 30 of culture. The images were then
analyzed using Image J v1.46 (National Insti-
tute of Health, Bethesda, MD). For each experi-
ment, 3 collagen gels containing keratocytes
which were either cultured in serum-free
medium (with RA or DMSO) or standard cul-
ture medium with serum (FBS) were evaluated
and the average contraction was determined by
calculating the percent decrease in surface area
compared to the original gel surface area.
Reverse Transcription Polymerase Chain
Reaction (RT-PCR) analysis
Following 30 days in culture, the com-
pressed collagen gels with embedded kerato-
cytes were harvested, and RNA was isolated
using standard Trizol (Invitrogen, 15596–018)
extraction. The assessment of RNA quality was
performed using Nanodrop 2000 spectropho-
tometer (Thermo Scientific, UK) to ensure the
260/280 ratio was within the range of 1.7 to
2.0. Synthesis of cDNA from isolated total
RNA was done using the RT2 First Strand kit
(Qiagen, 330401) according to the man-
ufacturer’s protocol, in a TcPlus thermocycler
(Techne, Staffordshire, UK). The polymerase
chain reaction (PCR) was carried out using
the default thermal profile of the Eco Real-
Time System (Illumina, San Diego, CA), with
the following 40 £ 3-step cycle: 10-second
denaturation, 95C; 30-second annealing, 60C;
15-second elongation, 72C. The relative expres-
sion of keratocyte genes coding (summarized in
Table 1) were calculated by the comparative
threshold cycle (CT) (Eco Software v3.1; Illu-
mina) and normalized to the expression of the
POLR2A housekeeping gene. Results from 3
independent experiments from 3 different donors
were normalized relative to the expression from
compressed collagen gels embedded with kera-
tocytes cultured using control media.
TABLE 1. Description of primers used in RT-PCR for keratocyte gene expression analysis
Gene Primers 50!30
POLR2A (housekeeping gene) F: cat cat cga aga caa tgg tgR: aac aat gtc ccc atc aca ca
Keratocan (KERA) F: tat tcc tgg aag gca agg tg R: acc tgc ctc aca ctt cta gac c
Lumican (LUM) F: cct ggt tga gct gga tct gt R: tag gat ggc ccc agg a
Decorin (DCN) F: aat tga aaa tgg ggc ttt cc R: ctg ctg att ttg ttg cca tc
Aldehyde dehydrogenase 1 (ALDH1) F: ctc tca ctg ctc tcc acg tg R: gag aag aaa tgg ctg ccc ct
Aldehyde dehydrogenase 3 (ALDH3) F: ccc ctt caa cct cac cat cc R: gtt ctc act cag ctc cga gg
Carbohydrate sulfotransferase 6 (CHST6) F: acg acg ttt ggg agc ctt t R: tag agg ttc ctc agc acc cca
Collagen Type V (COL5A) F: atc ttc caa agg ccc gga tg R: aaa tgc aga cgc agg gta ca
Matrix metalloproteases 1 (MMP 1) F: agg tct ctg agg gtc aag caR: ctg gtt gaa aag cat gag ca
Matrix metalloproteases 3 (MMP 3) F: tgc ttt gtc ctt tga tgc tg R: aag ctt cct gag gga ttt gc
a-smooth muscle actin (ACTA2) F: ctg agc gtg gct att cct tc R: ttc tca agg gag gat gag ga
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Western blotting
The expression of keratocan, lumican and
decorin proteoglycans, ALDH1 and ALDH3
crystallins, carbohydrate sulfotransferase 6
(CHST6), Collagen Type I and V, MMP1 and
MMP9 proteases, fibronectin and a-smooth
muscle actin (aSMA) were analyzed from day
30 compressed collagen gels embedded with
keratocytes in both RA-treated and control
groups lysates using ice-cold RIPA lysis buffer
supplemented with 1x Proteases Inhibitors
Cocktail (Roche, 04693116001) for 10 minutes.
Both human donor cornea and keratocytes
grown for 7 d in serum-containing medium
(bFBS) were used as controls. After precipita-
tion with 4 £ volumes of ethanol and pellet
resuspension in sample buffer, lysates were run
by reducing SDS-PAGE using 10% Mini-Pro-
tean precast gels (Bio-Rad, 4561034) and blot-
ted onto polyvinylidene difluoride (PVDF)
membranes (Thermo Scientific, 88518). Mem-
branes were then blocked in Tris-buffered
saline (Fisher Scientific, 10103203) supple-
mented with 5% bovine serum albumin (First-
Link, 40–00–450) and 0.1% Tween 20 (Fisher
Scientific, 10246910), and incubated with pri-
mary antibodies against keratocan (Santa Cruz
Biotechnology, sc-66941), lumican (kindly
given by Dr Bruce Caterson, Cardiff School of
Biosciences, Cardiff, UK), decorin (CalBio-
chem, PC673), ALDH1A1, MMP1, MMP9,
CHST6 (Abcam, ab23375, EP1247Y, EP1254,
ab154332 respectively), ALDH3A1 (Thermo
Scientific, 10304480), aSMA and fibronectin
(Vector Labs, VPS281 and VPF705, respec-
tively) diluted 1:500 in blocking solution,
followed by corresponding horseradish perox-
idise-conjugated secondary antibodies. Anti-
tubulin was used for protein loading normaliza-
tion. Quantification was performed by densi-
tometry analysis of imaged bands using Image
J v1.46 (National Institute of Health, Bethesda,
MD).
Immunofluorescence staining
Corneal constructs were imaged by immuno-
fluorescence microscopy. Briefly, 7 mm sections
of the gels were cut at ¡20C using a cryotome
(Leica Microsystems, Wetzlar, Germany) and
collected on adhesion glass slides (Thermo Sci-
entific, 640-ADH-006). Sections were fixed in
4% paraformaldehyde for 20 minutes prior to
incubation with 2% goat serum (Sigma-Aldrich,
G9023) and 2% bovine serum albumin (First-
Link) at room temperature to block non-specific
binding. Sections were then incubated overnight
at 4C with primary antibodies against kerato-
can, lumican, ALDH1, Collagen type I and V
(same as used for Western blotting). Incubation
with secondary antibodies was carried out for
1 hour using Alexa Fluor 488-conjugated goat
anti-mouse or anti-rabbit (1:200, Life Technolo-
gies, A11001 and A11008 respectively). Finally,
the slides were imaged by fluorescence micros-
copy (Carl Zeiss Meditec, Germany).
Data analysis and statistics
Error bars represent the SD of the mean. Dif-
ferences between groups were determined
using Student’s t-test. Significance between
groups was established for p < 0.05, denoted as
‘*’ within figures.
CONCLUSION
The greatest challenge in developing a bio-
engineered cornea has always been to recapitu-
late the biological corneal stroma within the
artificial scaffold. This study demonstrates that
RA can improve the quality of 3D collagen
gels as an in vitro model of the corneal stroma.
Furthermore, our results move the potential use
of RA a step forward suggesting that RA could
be used clinically. As RA supplementation
induced keratocytes within a 3D collagen gel
matrix to increase proteoglycans production,
particularly keratocan and lumican, and remain
non-contractile, it is possible that RA may help
reduce scarring following wound healing by
promoting proliferation and replacement with
normal keratocytes within corneal stroma
without the need for fibroblast/myofibroblast
transformation that can alter proteoglycan
132 Abidin et al.
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and collagen production and lead to corneal
haziness.
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